127 related articles for article (PubMed ID: 12351965)
1. Plasmablastic lymphoma of the oral cavity and jaws.
Borrero JJ; Pujol E; Pérez S; Merino D; Montaño A; Rodríguez FJ
AIDS; 2002 Sep; 16(14):1979-80. PubMed ID: 12351965
[No Abstract] [Full Text] [Related]
2. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection.
Riedel DJ; Gonzalez-Cuyar LF; Zhao XF; Redfield RR; Gilliam BL
Lancet Infect Dis; 2008 Apr; 8(4):261-7. PubMed ID: 18353267
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations.
Flaitz CM; Nichols CM; Walling DM; Hicks MJ
Oral Oncol; 2002 Jan; 38(1):96-102. PubMed ID: 11755827
[TBL] [Abstract][Full Text] [Related]
4. Treatment of opportunistic infections and lymphoma in the nervous system.
Loy CT; Brew BJ
J HIV Ther; 2002 Feb; 7(1):21-5. PubMed ID: 11956501
[TBL] [Abstract][Full Text] [Related]
5. Oral cavity lymphoma as secondary AIDS-defining neoplasm in a patient on HAART with immune reconstitution.
Corti M; Solari R; Cangelosi D; De Carolis L; Schtirbu R; Lewi D
Rev Soc Bras Med Trop; 2007; 40(5):582-4. PubMed ID: 17992417
[TBL] [Abstract][Full Text] [Related]
6. Disseminated plasmablastic lymphoma.
Sharma R; Abdou S; Plymyer MR; Rohatgi C
J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
[No Abstract] [Full Text] [Related]
7. Neurological manifestations of HIV-1 infection in the HAART era.
Geraci AP; Simpson DM
Compr Ther; 2001; 27(3):232-41. PubMed ID: 11569325
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy.
Navarro JT; Ribera JM; Oriol A; Tural C; Millá F; Feliu E
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):347-8. PubMed ID: 12626898
[No Abstract] [Full Text] [Related]
9. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
[TBL] [Abstract][Full Text] [Related]
10. Oral medicine case book 49: Plasmablastic lymphoma.
Stander S; Holmes H; Dreyer WP; Afrogheh A; Mohamed N; Hille J; Osman N
SADJ; 2013 May; 68(4):184-6. PubMed ID: 23971300
[No Abstract] [Full Text] [Related]
11. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
[TBL] [Abstract][Full Text] [Related]
12. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation.
Häusermann P; Khanna N; Buess M; Itin PH; Battegay M; Dirnhofer S; Buechner SA
Dermatology; 2004; 208(3):287-90. PubMed ID: 15118393
[TBL] [Abstract][Full Text] [Related]
14. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease?
Carbone A; Gloghini A; Gaidano G
Am J Surg Pathol; 2004 Nov; 28(11):1538-40; author reply 1540. PubMed ID: 15489661
[No Abstract] [Full Text] [Related]
15. HIV: the surgeon's perspective. Part 3. Diagnosis and management of malignant neoplasms.
Porter S; Scully C
Br J Oral Maxillofac Surg; 1994 Aug; 32(4):241-7. PubMed ID: 7947568
[No Abstract] [Full Text] [Related]
16. Plasmablastic lymphoma: a new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma.
Brown RS; Campbell C; Lishman SC; Spittle MF; Miller RF
Clin Oncol (R Coll Radiol); 1998; 10(5):327-9. PubMed ID: 9848336
[TBL] [Abstract][Full Text] [Related]
17. Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study.
Schommers P; Wyen C; Hentrich M; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Fätkenheuer G; Hoffmann C
AIDS; 2013 Mar; 27(5):842-5. PubMed ID: 23574794
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related lymphomas--potentially curable in the HAART era.
Valencia ME
AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
[No Abstract] [Full Text] [Related]
19. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
[TBL] [Abstract][Full Text] [Related]
20. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
